financetom
Business
financetom
/
Business
/
Pfizer Shares Are Trading Higher Tuesday: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer Shares Are Trading Higher Tuesday: What's Going On?
Sep 30, 2025 9:21 AM

Pfizer, Inc. ( PFE ) shares are trading higher on Tuesday after The Washington Post reported that President Donald Trump will announce a drug-pricing deal with the company.

What To Know: According to the report, Pfizer ( PFE ) has agreed to voluntarily sell its medications through Medicaid at lower prices as part of the White House's "Most Favored Nation" initiative, which aims to match U.S. drug prices to the lowest costs paid by other wealthy nations.

The agreement follows an executive order from Trump in May that set a framework for the initiative. Officials have reportedly been in talks with pharmaceutical companies about lowering prices since, but the deadline for those agreements was Monday.

The pharmaceutical industry has also sought to address Trump's demands, with its main lobbying group announcing voluntary steps this week, including a new website to help Americans find lower-cost drugs.

Trump has argued the U.S. pays disproportionately high prices for medications compared to other countries.

“We're not doing that anymore,” Trump said last week.

The Trump administration is expected to make an official announcement with Pfizer ( PFE ) on Tuesday.

How To Buy PFE Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Pfizer's ( PFE ) case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

PFE Price Action: At the time of writing, Pfizer ( PFE ) shares are trading 2.87% higher at $24.54, according to data from Benzinga Pro.

Read Next:

Stock Market Today: Nasdaq, Dow Futures Slip As Shutdown Standoff Drags On—Cigna, Wolfspeed, Nike In Focus

Image via Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
Oct 2, 2024
Oct 2 (Reuters) - Gilead Sciences ( GILD ) said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in 120 low and lower-middle income countries. The U.S.-based drugmaker also plans to provide the companies branded version of the drug, lenacapavir, in 18 countries, such...
StandardAero valued at $10.4 bln as shares jump in NYSE debut
StandardAero valued at $10.4 bln as shares jump in NYSE debut
Oct 2, 2024
Oct 2 (Reuters) - StandardAero's ( SARO ) shares opened 29% above the initial public offering price in their market debut on Wednesday, giving the Carlyle-backed aviation maintenance services provider a market value of about $10.4 billion. (Reporting by Niket Nishant and Prakhar Srivastava in Bengaluru; Editing by Sriraj Kalluvila) ...
StandardAero valued at $10.4 billion as shares jump in NYSE debut
StandardAero valued at $10.4 billion as shares jump in NYSE debut
Oct 2, 2024
(Reuters) - StandardAero's ( SARO ) shares opened 29% above the initial public offering price in their market debut on Wednesday, giving the Carlyle-backed aviation maintenance services provider a market value of about $10.4 billion. (Reporting by Niket Nishant and Prakhar Srivastava in Bengaluru; Editing by Sriraj Kalluvila) ...
OpenAI closes $6.6 billion funding haul at valuation of $157 billion with investment from Microsoft and Nvidia
OpenAI closes $6.6 billion funding haul at valuation of $157 billion with investment from Microsoft and Nvidia
Oct 2, 2024
Oct 2 (Reuters) - OpenAI has raised $6.6 billion from investors at a post-money valuation of $157 billion, cementing the ChatGPT maker's status as one of the most valuable private companies in the world, sources familiar with the matter said on Wednesday. The funding has attracted returning venture capital investors including Thrive Capital and Khosla Ventures, as well as OpenAI's...
Copyright 2023-2026 - www.financetom.com All Rights Reserved